Artificial Intelligence for Acne Diagnosis in a 2026 Scoping Review: How Teledermatology Patients Can Compare Acne Apps

Frederickson and colleagues reviewed 105 acne-AI studies, mostly image-based diagnosis tools, with combined ensemble models averaging 89.7% accuracy. Teledermatology patients — people who get skin care by photo or video — can compare acne apps by checking FDA status, clinician input, validation evidence and privacy terms. Dermatology Times described the review methods and findings in its digest of the November dermatology journals.

A scoping review maps all published research on a topic. This one shows progress on photo-based acne diagnosis but also gaps in testing, regulation and follow-through. Use it to ask sharper questions before you upload photos.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

What the 105-study review found
Will it work on your skin tone?
How do you compare acne apps?
Can AI help you decide what to do next?
When can an app lead to a prescription?

What the 105-study review found

The team searched PubMed, Cochrane and Scopus and included 105 studies, as summed up by Dermatology Times. About 96% focused on acne diagnosis. About 76% used image-based deep learning, a method that learns patterns from photos.

Ensemble models averaged the highest diagnostic accuracy at 89.7%. That figure reflects controlled study testing, not everyday phone photos in varied light. Treat it as a signal of progress, not a promise for any single app.

Will it work on your skin tone?

Only 13% of studies reported patient skin color or ethnicity. Under 4% included skin-tone data when building models, according to Dermatology Times.

That gap matters because acne looks different across tones and lighting. A tool trained mainly on light skin may miss inflammation or dark marks on darker skin. Ask vendors if they tested on tones like yours and on acne types like yours.

How do you compare acne apps?

AJMC covered a separate JAMA Dermatology review that screened 909 store apps down to 41 AI dermatology apps. About 78% were patient-facing, and none had FDA approval, in that review of app safety gaps. Disclosure was thin.

Only 2 of 14 U.S.-based apps stated the lack of FDA approval. Use this checklist when you compare acne apps: Save screenshots of claims and terms. If an app cannot answer these points, choose one that can.

FDA status: does the listing state clearance or clearly state none
Clinician input: who reviews photos and when
Validation evidence: what testing supports acne claims
Privacy terms: how photos are stored, shared and deleted

Can AI help you decide what to do next?

Managed Healthcare Executive reported on a 2026 JAMA Dermatology randomized study of 2,345 consumers viewing 127 teledermatology cases in its summary of the consumer AI study. AI raised diagnostic accuracy to 22.8% versus 7.9% for web search, but stayed below 36.2% for dermatologist panels.

The same study raised confidence to 62.3% with AI versus 41.2% without it. It did not improve understanding of next care steps. Use AI for a starting idea, then confirm the plan with a clinician.

When can an app lead to a prescription?

Medical Economics reported that Utah authorized Nolla Derm on Oct 5 2026 to issue initial acne prescriptions for adults 18 and older at $4.99/month under tiered physician oversight in its report on the Utah launch. Eligibility, price and oversight matter more than marketing language.

The FDA database lists DermaSensor DEN230008, decided Jan 12 2024, as a software-aided adjunctive device for physicians evaluating lesions suspicious for skin cancer. It is not a consumer acne diagnoser. Before you pay, confirm age rules, prescription limits, follow-up care and how your photos are stored.